Beth Y. Karlan, MD
Cedars-Sinai Women’s Cancer Research Institute
Samuel Oschin Comprehensive Cancer Institute
Dr. Beth Karlan, the Director of the Cedars-Sinai Women’s Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute, is a world- renowned expert in the field of gynecologic oncology, specifically ovarian cancer surgery, early detection, targeted therapies and inherited cancer susceptibility. She is past-president of the Society of Gynecologic Oncologists, the Editor-in-Chief of Gynecologic Oncology, and has held many international leadership positions. She is commitment to both scientific advancement and enhancing public awareness about gynecologic cancers.
Dr. Karlan is a graduate of Harvard College and Harvard Medical School. She completed her residency training in obstetrics and gynecology and a post-doctoral fellowship in molecular biology at Yale University School of Medicine. Currently, she is Professor of Obstetrics and Gynecology at the David Geffen School of Medicine, and also directs the Division of Gynecologic Oncology and the Gilda Radner Hereditary Cancer Detection Program at Cedars-Sinai.
